Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting ( Forward-looking statements Some of...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting

Forward-looking statements

Some of the statements in this press release are forward looking. Such statements are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Merck Serono S.A. and affiliates to be materially different from those expected or anticipated in the forward-looking statements. Forward-looking statements are based on Merck Serono’s current expectations and assumptions, which may be affected by a number of factors, including those discussed in this press release and more fully described in Serono’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on February 28, 2006. These factors include any failure or delay in Merck Serono’s ability to develop new products, any failure to receive anticipated regulatory approvals, any problems in commercializing current products as a result of competition or other factors, our ability to obtain reimbursement coverage for our products, the outcome of any government investigations and litigation. Merck Serono is providing this information as of the date of this press release, and has no responsibility to update the forward-looking statements contained in this press release to reflect events or circumstances occurring after the date of this press release.

###

About Newron Pharmaceuticals

Newron Pharmaceuticals S.p.A. (www.newron.com) is a biopharmaceutical company focused on novel therapies for diseases of the Central Nervous System and pain. Newron is undertaking phase III trials with safinamide, a unique molecule with multiple mechanisms of action, for the treatment of PD in conjunction with its partner, Merck Serono S.A., which has the rights to develop the compound in PD, Alzheimer´s disease, other cognitive disorders and Restless Legs Syndrome. Recent results
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
2. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
3. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
4. Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
5. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:

(Date:11/9/2009)... Nov. 9 Cardiac Scienc...in automated external defibrillator ( AED ) and ...nced revenue of $38.9 million for the third quarte...ous guidance. The Company also recorded a charge o...d a non-cash charge of $44.0 million to increase i...

(Date:11/9/2009)...Nov. 9 Boston Scientific...edule of events at the 38th annual Global Congress...uns from November 15-19 in Orlando, Florida. Resu...aturing the Company,s Urology/Gynecology products,... mid-urethral sling systems used to treat pelvic f...

(Date:11/9/2009)...NCETON, N.J., Nov. 9 Pha...t will present at the Sixth Annual Lazard Capital ... be held at the St Regis Hotel in New York City (N...sset,s President and Chief Executive Officer, will...November 18, 2009 at 3:45 PM (ET). ,, To access...

[0] Cardiac Science Announces Third Quarter Results [0] Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress [0] Pharmasset to Present at Lazard Capital Markets Healthcare Conference

...Nektar Therapeutics,(Nasdaq: NKTR ) announced tod...for its pipeline programs will be presented at num...ing months. These presentations will,highlight Nek... oncology,anti-infectives and central nervous syst... molecule PEGylation and liquid aerosol platforms....

...w devices and research for,mechanical circulatory ...,of Health (NIH) National Heart, Lung, and Blood I...gram will be discussed at the International Societ...Annual Meeting and,Scientific Sessions. The meetin...ey Place and Hynes Convention Center., The use of...

Other Medicine Technology:Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 2 Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 3 Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 4 New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2

Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting

(Date:11/9/2009)...HINGTON, Nov. 9 The Churchill Ce...ward For Leadership to J.W. "Bill" Marriott for hi...gh progressive free market practices and fostering...Mr. Marriott will receive his award at a ceremony ...on D.C. Four Seasons Hotel. ,, "This is a test...

(Date:11/9/2009)...lped men and women almost equally, study finds, ,...e widely used clot-dissolving drug Plavix (clopido...analysis of major clinical trials has found. , ...n treating both men and women with this very impor...f cardiovascular thrombosis at New York University...

(Date:11/9/2009)...n of plans finds differences in mood despite simil...hDay News) -- Both a high-fat, low-carbohydrate di...t, high-carb diet appear to help people lose pound...? Only the low-fat diets will result in long-term ...ov. 9 issue of Archives of Internal Medicine . ,...

(Date:11/9/2009)... Tomorrow may be too late when it ...ion, according to TOPS Club, Inc. (Take Off Pounds...nization. , (Vocus) Novem...mes to preventing or improving a diabetes conditio...ensibly), the nonprofit weight-loss support organi...

(Date:11/9/2009)...ANON, Tenn., Nov. 9 Health Connect...ced it will host their inaugural Hospital O.R. and...at the Marriott Renaissance Hotel in Nashville, Te...e than 100 hospital operating room directors and m...lth systems in the country. Some of the confirmed ...

Breaking Medicine News(10 mins):Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2 Health News:No Gender Gap Found for Clot-Busting Drug 2 Health News:No Gender Gap Found for Clot-Busting Drug 3 Health News:To Feel Better, Low-Fat Diet May Be Best 2 Health News:To Feel Better, Low-Fat Diet May Be Best 3 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2 Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3 Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2

[0] J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership [0] No Gender Gap Found for Clot-Busting Drug [0] To Feel Better, Low-Fat Diet May Be Best [0] Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says [1] Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference

...tra El Cancer, an,organization dedicated to improv...ancer and their families, will host its Annual Hol...ients this Saturday, December 13, 2008. , Ch...ebrating holiday traditions. In addition to the s...

...Vital Images, Inc. (Nasdaq: VTAL ) , a leadin...on and analysis solutions, has named Ray A. Ghanba...d Products, a new position at ViTAL. Ghanbari repo...elopment and driving strategic business planning. ...

... this,afternoon by some major Michigan newspapers,...rmation about Executive Order (EO) budget cuts pro...y, the stories mistakenly reported:,"Another $5.3 ...ealth care treatment delivered to Medicaid patient...

...ER treatment, elective procedures, study says , ...re could be a shortage of 1,300 general surgeons i...at shortage could increase to 6,000 by 2050, a new...ency departments. A shortage of general surgeons m...

...consecutive year,hundreds of Conseco employees in ...eer for the needy of central Indiana as part of th...oliday season, Conseco partners with the United Ch...volunteers often add their,own donations and perfo...

...ernacional,S.A.B. de C.V. (BMV: LAB) ("Genomma Lab...unter ("OTC") pharmaceuticals and personal care pr...uidance. The Company expects to reach,organic gro...sed on the organic growth of core products (produc...

Other Medicine News:Health News:PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer 2 Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 2 Health News:Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products 3 Health News:U.S. May Soon Face Shortage of General Surgeons 2 Health News:Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families 2 Health News:Genomma Lab Announces 2009 Earnings Guidance 2

PADRES Contra El Cancer to Host its 10th Annual Posada Holiday Celebration for Children with Cancer Vital Images Names Healthcare Veteran Ray Ghanbari Executive Vice President of Strategy and Products Michigan Governor's Executive Order Budget Cuts Do Not Cut Payments to Medicaid Patients U.S. May Soon Face Shortage of General Surgeons Conseco Employees Provide Holiday Cheer for 40 Central Indiana Families Genomma Lab Announces 2009 Earnings Guidance

...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...

Medicine Products:

Vancocin, Peak Level Valproic Acid, Free & Total Valley Fever (Serum)Valium

( Forward-looking statements Some of...)Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting,Health